Pharma products sold under others' brand names don't get SSI exemption; penalty rules clarified under Section 11A(4) and 11AC

The CESTAT upheld that pharmaceutical preparations sold under brand names of others do not qualify for SSI exemption under N/N 8/2003-CE. The appellant's failure to register or file returns and concealment of manufacturing goods with others' brand names justified invocation of the extended limitation period under section 11A(4). Consequently, the mandatory penalty under section 11AC was upheld, while the penalty under Rule 27 was set aside as redundant. Penalty under Rule 26 imposed on the individual was also quashed due to lack of confiscation or issuance of invoices without supply. The appeal was allowed in part.

---

---

ISSUES:

Whether goods manufactured bearing the brand name or trade name of another person are eligible for exemption under Notification No. 8/2003-CE.Whether the absence of brand name registration with the patents department affects the applicability of exemption under Notification No. 8/2003-CE.Whether permission or licence from the brand name owner is necessary for determining exemption eligibility under Notification No. 8/2003-CE.Whether the extended period of limitation under section 11A(4) of the Central Excise Act, 1944 can be invoked in the facts of the case.Whether penalty under section 11AC of the Act and Rules 26 and 27 of the Central Excise Rules, 2002 are justified and correctly imposed.Whether goods exempt under Notification No. 12/2012-CE (e.g., chloroquine preparations) are liable to excise duty demand.Whether penalty under Rule 26 is sustainable in absence of confiscation or issuance of invoices without delivery of goods.

RULINGS / HOLDINGS:

Goods bearing the brand name or trade name of another person, "whether registered or not," are not eligible for exemption under Notification No. 8/2003-CE as per paragraph 4 of the notification.The lack of registration of brand names with the patents department does not affect the applicability of Notification No. 8/2003-CE; the exemption excludes goods bearing unregistered brand names of others as well.Permission or licence from the brand name owner is not a prerequisite for determining exemption eligibility; manufacturing goods with another's brand name without licence does not confer exemption under Notification No. 8/2003-CE.The extended period of limitation under section 11A(4) was correctly invoked due to suppression of facts and manufacture of goods with brand names of others without paying duty.Penalty under section 11AC of the Act is mandatory where non-payment or short payment of duty is due to "fraud or collusion or wilful misstatement or suppression of facts or contravention" with intent to evade duty, and is upheld in this case.Penalty under Rule 27 of the Central Excise Rules, 2002 is not applicable where penalty under section 11AC is imposed; thus, penalty under Rule 27 on the assessee is set aside.Penalty under Rule 26 is unsustainable absent confiscation of goods or issuance of invoices without delivery; penalty under Rule 26 imposed on the director is set aside.Excise duty demand does not apply to preparations of chloroquine as they are exempted under Notification No. 12/2012-CE; demand was correctly computed excluding such goods.Demand and penalties related to goods cleared under the brand name 'Ranemax', which belongs to the manufacturer, are set aside.

RATIONALE:

The Court applied the provisions of Notification No. 8/2003-CE, 1.3.2003, particularly paragraph 4, which excludes exemption for goods bearing brand names of others, regardless of registration status, relying on the plain language of the notification.Section 11A(4) of the Central Excise Act, 1944, allowing extended period of limitation, was invoked due to suppression of facts and non-payment of duty on goods bearing others' brand names, consistent with statutory intent to prevent evasion.Section 11AC of the Act imposes mandatory penalties where duty evasion involves "fraud or collusion or wilful mis-statement or suppression of facts," which was found applicable on the facts established by the investigation and invoices examined.Rule 26 and Rule 27 penalties under the Central Excise Rules, 2002 were interpreted strictly; Rule 27 penalty is inapplicable when section 11AC penalty is imposed, and Rule 26 requires confiscation or issuance of false invoices, neither of which was established.The Court emphasized that exemption notifications are to be strictly construed and that the burden of proving eligibility for exemption lies on the manufacturer, who failed to demonstrate that goods bearing brand names of others qualified for exemption.The Court recognized that the absence of license from brand owners does not affect the applicability of exemption provisions, distinguishing between legal disputes over brand use and statutory exemption eligibility.The Court remanded the matter for recomputation of duty, interest, and penalty after excluding goods under the manufacturer's own brand name and those exempt under Notification No. 12/2012-CE, reflecting a partial doctrinal adjustment in relief granted.

---